跳至主要内容
临床试验/IRCT201101122709N16
IRCT201101122709N16已完成未知

The Comparison of The Effect of Eicosapentaenoic Acid and Docosahexaenoic Acid on Helicobacter pylori Infection Eradication and Some Serum Inflammatory Factors

Vive-chancellor for Research, Tehran University of Medical Sciences0 个研究点目标入组 105 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
All

入选标准

  • - positive stool antigen test result
  • - no history of pharmaceutical treatment for infection eradication
  • - no gastric surgery
  • - no history of peptic ulcer
  • - no any disease that cause inflammation & increase of serum inflammatori markers level such as diabetes, CVD, respiratoryinflammations such as asthma,...
  • - no consumption of any drug other than prescribed drugs during the study
  • - no consumption of antibiotic or bismut during 2 months before the trial
  • - no consumption of antioxidant supplements such as Se, Zn, beta-caroten,... at least 3 months before the trial
  • - no consumption of omega-3 supplements at least 3 months before the trial
  • - no smoking
  • - BMI less than 30
  • - age between 20-60 years old
  • -leaning to cooperation
  • Exclusion criteria:
  • - no leaning to continuing the cooperation
  • - any change in type or dose of prescribed drugs
  • - any change in daily diet or physical activity
  • - consumption of any antioxidant supplement
  • - consumption of less than 70% of supplements given to patients at the start of the study

排除标准

  • 未提供

研究者

发起方
Vive-chancellor for Research, Tehran University of Medical Sciences

相似试验